Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation
- 13 December 2012
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 91 (3) , 436-443
Abstract
Many antiepileptic drugs (AEDs) exert their therapeutic activity by modifying the inactivation properties of voltage‐gated sodium (Nav) channels. Lacosamide is unique among AEDs in that it selectively enhances the slow inactivation component. Although numerous studies have investigated the effects of AEDs on Navchannel inactivation, a direct comparison of results cannot be made because of varying experimental conditions. In this study, the effects of different AEDs on Navchannel steady‐state slow inactivation were investigated under identical experimental conditions using whole‐cell patch‐clamp in N1E‐115 mouse neuroblastoma cells. All drugs were tested at 100 μM, and results were compared with those from time‐matched control groups. Lacosamide significantly shifted the voltage dependence of Navcurrent (INa) slow inactivation toward more hyperpolarized potentials (by −33 ± 7 mV), whereas the maximal fraction of slow inactivated channels and the curve slope did not differ significantly. Neither SPM6953 (lacosamide inactive enantiomer), nor carbamazepine, nor zonisamide affected the voltage dependence of INaslow inactivation, the maximal fraction of slow inactivated channels, or the curve slope. Phenytoin significantly increased the maximal fraction of slow inactivated channels (by 28% ± 9%) in a voltage‐independent manner but did not affect the curve slope. Lamotrigine slightly increased the fraction of inactivated currents (by 15% ± 4%) and widened the range of the slow inactivation voltage dependence. Lamotrigine and rufinamide induced weak, but significant, shifts of INaslow inactivation toward more depolarized potentials. The effects of lacosamide on Navchannel slow inactivation corroborate previous observations that lacosamide has a unique mode of action among AEDs that act on Navchannels.Keywords
This publication has 30 references indexed in Scilit:
- The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticusEpilepsy Research, 2011
- Development and Characterization of Novel Derivatives of the Antiepileptic Drug Lacosamide That Exhibit Far Greater Enhancement in Slow Inactivation of Voltage-Gated Sodium ChannelsACS Chemical Neuroscience, 2010
- Lacosamide and EpilepsyCNS Neuroscience & Therapeutics, 2010
- Saliva and serum lacosamide concentrations in patients with epilepsyEpilepsia, 2010
- NaV1.1 channels and epilepsyThe Journal of Physiology, 2010
- Differential Block of Sensory Neuronal Voltage-Gated Sodium Channels by Lacosamide [(2 R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide], Lidocaine, and CarbamazepineThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Comparison of the Pharmacological Properties of Rat NaV1.8 with Rat NaV1.2a and Human NaV1.5 Voltage-Gated Sodium Channel Subtypes Using a Membrane Potential Sensitive Dye and FLIPRRReceptors and Channels, 2004
- Interaction of the Novel Anticonvulsant, BIA 2‐093, with Voltage‐Gated Sodium Channels: Comparison with CarbamazepineEpilepsia, 2001
- Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neuronesBritish Journal of Pharmacology, 1997
- Zonisamide enhances slow sodium inactivation inMyxicolaBrain Research, 1987